Exact Sciences Corporation

About Exact Sciences Corporation

Exact Sciences Corporation is a leading molecular diagnostics company focused on the early detection and prevention of cancer. Established with a mission to save lives through innovative testing solutions, the company has developed a range of non-invasive tests that help in the early diagnosis of various cancers.

With a strong emphasis on research and development, Exact Sciences is committed to advancing the field of oncology. The company’s flagship product, Cologuard, is a groundbreaking stool DNA test for colorectal cancer screening, which has been widely adopted across the United States and is gaining traction internationally.

Exact Sciences operates with a vision to transform cancer care by providing patients and healthcare providers with accurate and timely information. The company collaborates with leading healthcare professionals and institutions to enhance its testing capabilities and expand its product offerings.

• Innovative Solutions: Exact Sciences is dedicated to developing cutting-edge diagnostic tests that improve patient outcomes.
• Commitment to Quality: The company adheres to the highest standards of quality and regulatory compliance in all its operations.
• Patient-Centric Approach: Exact Sciences prioritises the needs of patients, ensuring that its tests are accessible and easy to use.

Headquartered in Madison, Wisconsin, Exact Sciences has a growing workforce of skilled professionals who are passionate about making a difference in the fight against cancer. The company continues to expand its global presence, aiming to reach more patients and healthcare providers worldwide.

Through its dedication to innovation and excellence, Exact Sciences Corporation is poised to lead the way in cancer diagnostics, ultimately contributing to better health outcomes for individuals at risk of cancer.